153 related articles for article (PubMed ID: 25394326)
1. A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.
Johnson LA; Sohrabi HR; Hall JR; Kevin T; Edwards M; O'Bryant SE; Martins RN
Int J Geriatr Psychiatry; 2015 Aug; 30(8):881-6. PubMed ID: 25394326
[TBL] [Abstract][Full Text] [Related]
2. A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders.
Johnson LA; Gamboa A; Vintimilla R; Edwards M; Hall J; Weiser B; Yadav M; Dickensheets T; O'Bryant SE
J Alzheimers Dis; 2016 Jul; 54(1):201-6. PubMed ID: 27472872
[TBL] [Abstract][Full Text] [Related]
3. A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
Johnson LA; Hall JR; O'Bryant SE
PLoS One; 2013; 8(7):e68848. PubMed ID: 23874786
[TBL] [Abstract][Full Text] [Related]
4. Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort.
Johnson LA; Edwards M; Gamboa A; Hall J; Robinson M; O'Bryant SE
Int Psychogeriatr; 2017 Oct; 29(10):1693-1699. PubMed ID: 28629481
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
[TBL] [Abstract][Full Text] [Related]
6. Exaggerated reaction to novelty as a predictor of incipient cognitive decline among community-dwelling older adults.
Suchy Y; Franchow EI; Niermeyer MA; Ziemnik RE; Williams PG; Pennington NN
J Clin Exp Neuropsychol; 2018 Dec; 40(10):987-999. PubMed ID: 30112978
[TBL] [Abstract][Full Text] [Related]
7. Depression and Cognitive Impairment in Institutionalized Older Adults.
Camacho-Conde JA; Galán-López JM
Dement Geriatr Cogn Disord; 2020; 49(1):107-120. PubMed ID: 32634807
[TBL] [Abstract][Full Text] [Related]
8. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
[TBL] [Abstract][Full Text] [Related]
9. Normative scores of the Cambridge Cognitive Examination-Revised in healthy Spanish population.
Pereiro AX; Ramos-Lema S; Juncos-Rabadán O; Facal D; Lojo-Seoane C
Psicothema; 2015; 27(1):32-9. PubMed ID: 25633767
[TBL] [Abstract][Full Text] [Related]
10. Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms.
Markova H; Andel R; Stepankova H; Kopecek M; Nikolai T; Hort J; Thomas-Antérion C; Vyhnalek M
J Alzheimers Dis; 2017; 59(3):871-881. PubMed ID: 28697555
[TBL] [Abstract][Full Text] [Related]
11. Predictors of agreement between general practitioner detection of dementia and the revised Cambridge Cognitive Assessment (CAMCOG-R).
Pond CD; Mate KE; Phillips J; Stocks NP; Magin PJ; Weaver N; Brodaty H
Int Psychogeriatr; 2013 Oct; 25(10):1639-47. PubMed ID: 23800652
[TBL] [Abstract][Full Text] [Related]
12. Using informant reports to detect cognitive decline in mild cognitive impairment.
Tsang RS; Diamond K; Mowszowski L; Lewis SJ; Naismith SL
Int Psychogeriatr; 2012 Jun; 24(6):967-73. PubMed ID: 22300542
[TBL] [Abstract][Full Text] [Related]
13. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
14. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
Athey RJ; Porter RW; Walker RW
Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
[TBL] [Abstract][Full Text] [Related]
15. The impact of subjective memory complaints on quality of life in community-dwelling older adults.
Maki Y; Yamaguchi T; Yamagami T; Murai T; Hachisuka K; Miyamae F; Ito K; Awata S; Ura C; Takahashi R; Yamaguchi H
Psychogeriatrics; 2014 Sep; 14(3):175-81. PubMed ID: 25142381
[TBL] [Abstract][Full Text] [Related]
16. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
17. Role of depression in predicting time to conversion to mild cognitive impairment.
Dean K; Oulhaj A; Zamboni G; deJager CA; Wilcock GK
Am J Geriatr Psychiatry; 2014 Jul; 22(7):727-34. PubMed ID: 23611364
[TBL] [Abstract][Full Text] [Related]
18. Reduced serum levels of adiponectin in elderly patients with major depression.
Diniz BS; Teixeira AL; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
J Psychiatr Res; 2012 Aug; 46(8):1081-5. PubMed ID: 22633396
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
Buckley R; Saling MM; Ames D; Rowe CC; Lautenschlager NT; Macaulay SL; Martins RN; Masters CL; O'Meara T; Savage G; Szoeke C; Villemagne VL; Ellis KA;
Int Psychogeriatr; 2013 Aug; 25(8):1307-15. PubMed ID: 23693133
[TBL] [Abstract][Full Text] [Related]
20. Unique effects of apathy and depression signs on cognition and function in amnestic mild cognitive impairment.
Zahodne LB; Tremont G
Int J Geriatr Psychiatry; 2013 Jan; 28(1):50-6. PubMed ID: 22368079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
